Trends and current status in anticancer therapy for older patients with non-small cell lung cancer in Japan, 2016-2021
{{output}}
Introduction: Anticancer therapy for non-small cell lung cancer in patients ≥ 75 years has evolved with accumulating evidence. Recent guidelines recommend that treatment decisions be based on functional status rather than age al... ...
